Origen Scientific sells research compounds for in-vitro laboratory research only. They are not for human or animal use.
By entering, you confirm that you are 21 or older and will use our products for laboratory research only.
Sorry, you must be 21 or older to visit Origen Scientific.
Cat. No. GLP3RT | 20 mg per vial | Single compound
Orders submitted before 2 PM ET dispatch the same business day after approval and payment confirmation. U.S. shipping is $15 per order, free on orders of $250 or more.
Quantity savings are applied automatically. Retail orders allow up to 10 vials per product.
Applies to our peptide products. Request your batch-specific report →
GLP-3RT (research designation Retatrutide, RETA) is a triple-agonist incretin-class research peptide corresponding to the GLP-1, GIP, and glucagon receptor classes, supplied as a single 20 mg lyophilized research aliquot for laboratory use only.
Research use only. Not for human or animal use.
| Form | Lyophilized powder |
|---|---|
| CAS Number | 2381089-83-2 |
| Total Compound Content | 20 mg per vial |
| Synonyms | Retatrutide; LY3437943; GLP-3RT |
|---|
Its literature spans receptor characterization and experimental model systems. Refer to the original publication for the precise compound, assay, and study conditions.
LY3437943 has been characterized as an agonist at three receptor classes: GIP, GLP-1, and glucagon. The cited discovery paper examines receptor activity alongside preclinical and clinical research; it does not validate this particular vial.
The authors characterized LY3437943 activity at GIP, GLP-1, and glucagon receptors and investigated responses across experimental models. The work identifies the compound behind the retatrutide research designation.
Coskun T et al. · Cell Metab · 2022 · PMID 35985340These publications describe their own experimental materials and models, not testing of this product. Research-use policy →
